Synopsis
========

In this pilot study of ten patients, increased mastectomy flap length, a significant drop in medial and inferior StO~2~measurements by Optical Diffusion Imaging Spectroscopy (ViOptix T.Ox Tissue Oximeter) intra-operatively predicted post-operative mastectomy skin flap necrosis.

Introduction
============

Breast cancer is diagnosed in approximately 200,000 women in the United States every year. Surgical treatment for breast cancer involves either breast conserving surgery (BCT) or total mastectomy. Although recent studies \[[@B1]\] indicate that the majority of patients diagnosed with breast cancer receive BCT, 33% of patients continue to undergo mastectomy \[[@B1]\]. There also appears to be a significant improvement in the utilization of post-mastectomy reconstruction across the country \[[@B2]\]. Although the benefits of immediate reconstruction after mastectomy are well-documented \[[@B3]\], it has also been demonstrated that immediate reconstruction does increase the rate of post-operative wound complications \[[@B4]\]. Wound complications following mastectomy are estimated to be between 18-30% \[[@B5],[@B6]\]. Common complications include partial flap necrosis, epidermolysis and eschar formation.

Overall cosmetic outcome is highly dependent on the viability of mastectomy skin flaps. There is currently no accepted standard for evaluating skin flaps in the intra-operative setting. Techniques which are utilized include the injection of fluorescein, evaluation of \"bleeding edges\", and subjective assessment of capillary refill. Near Infrared Spectroscopy is a non-invasive method used to monitor blood perfusion to skin flaps. The unit of measurement is StO~2~. This is a measurement of the ratio of oxyhemoglobin (HgbO~2~) and deoxyhemoglobin (Hgb) in order to obtain noninvasive, real-time measurement of tissue pO~2~. This technique has previously been validated and is commonly used by plastic and reconstructive surgeons to assess the perfusion and viability of donor digital implants and microsurgical free tissue transfers \[[@B7]-[@B9]\]. The current pilot study evaluates the ability of near infrared spectroscopy to predict post-mastectomy skin flap necrosis in 10 patients.

Methods
=======

Approval for the protocol was obtained from the Institutional Review Board at the University of Texas Southwestern Medical Center. Ten patients undergoing mastectomy at a single institution were selected for the study. Data recorded included patient age, height/weight, co-morbidities, smoking history, medical history, tumor size, pathology and stage.

Tissue Oximeter
---------------

The ViOptix T.Ox Tissue Oximeter Tissue Oximeter^®^made by ViOptix, Inc. (Fremont, CA) was used to obtain tissue oxygen saturation (StO~2~) measurements. Near-infrared lights of 690-nm and 830-nm wavelengths are emitted at a scan rate of up to 40 Hz and are transmitted to the tissue through a special quartz fiberglass cable. The light is absorbed, scattered, and reflected in the layers of the tissue up to 10 mm deep, including the capillary loops and dermal plexus. The light is absorbed by biological compounds known as chromophores, whose absorption properties are oxygen-dependent. Common chromophores include hemoglobin, myoglobin, and cytochrome c oxidase. The volume of tissue under investigation is determined by the depth of near infrared light penetration (10 mm). The amount of light recovered from tissues is dependent on the intensity of incident light, separation of the optodes, degree of light scattering in tissues, and amount of absorption by chromophores. Since the intensity, distance between the optodes and light scattering are controlled, the changes in recovered light can be attributed to the variation in the concentration of chromophores. The recovered light is then processed by an integrated computer performing a fingerprint analysis of the spectral data. The data is then displayed in real-time, numerically, on a monitor.

Patients
--------

A cohort of patients was selected who were undergoing mastectomy\--both skin-sparing and traditional mastectomy patients were chosen to more accurately reflect the heterogeneity encountered by the practicing surgeon. Measurements were made preoperatively, and immediately after dissection at the following locations: superior mastectomy skin flap; lateral mastectomy skin flap; medial mastectomy skin flap; inferior mastectomy skin flap; and 2 cm inferior to the clavicle (Figure [1](#F1){ref-type="fig"}). Method of reconstruction, mastectomy operative time, measurements of the thickness of each skin flap, and length from clavicle to superior edge of the mastectomy skin flap were all recorded.

![**Cardinal points of measurement pre-operatively**.](1477-7819-7-91-1){#F1}

Measurements
------------

Flap thickness was measured by allowing the skin to lie in a neutral position against the chest wall and then utilizing an intra-operative ruler to measure the skin flap at its most distal aspect. Flap length was defined as the superior flap length, this area was measured since this is typically the longest flap in a mastectomy. It was measured by allowing all skin to lie in a neutral position and measuring the distance, in cm, from the edge of the superior portion of the incision at the 12 o\'clock position to the clavicle, care was taken to ensure that a straight line was maintained during this measurement. All complications were noted; presence and total area of epidermolysis was noted and recorded. Patients were followed for four weeks post-operatively to estimate the area of necrosis, evaluate for wound infection, and seroma formation. De-identified data was entered into a Microsoft Excel^®^database. Statistical analysis was performed using Wilcoxon Rank Sum test and Student\'s *t*-test.

Results
=======

Of the 10 patients in this study, 1 (10%) developed significant mastectomy skin flap necrosis. Measurements were obtained during the operation, the first one just prior to dissection, and the 2^nd^at the completion of the mastectomy, comparisons were then performed between these numbers. Statistically significant factors predicting post-op necrosis included reductions in medial (p = 0.0189) and inferior (p = 0.003) StO~2~levels, and flap length (p = 0.009) (Table [1](#T1){ref-type="table"}). In the patient who experienced necrosis, medial StO~2~reduction was 61% (p = 0.049), corresponding with an absolute medial StO~2~reduction of 42 points. Patients who did not have necrosis actually had an increase in their medial StO~2~of 14.6%, corresponding with an absolute medial StO~2~increase of 6.7 points. The patient with necrosis had a 69% decrease in inferior StO~2~levels, corresponding with a 65.5 point drop (p = 0.003). Patients without necrosis demonstrated a 20% increase in inferior StO~2~levels, corresponding with a 9.8 point increase in absolute StO~2~levels. The patient with necrosis had a 15 cm flap length, as opposed to a 11.9 cm average flap length in the other 9 patients (p = 0.009).

###### 

Analysis of patients with and without necrosis

  ----------------------------------------------------------------------------------------------------------
                                                   Necrosis                                   
  ------------------------------------------------ -------------------- --------------------- --------------
  **Age**                                          57                   48                    0.278

  **Seroma**                                       0                    1                     

  **Infection**                                    0                    1                     

  **Diabetes**                                     0                    2                     

  **Radiation**                                    0                    1                     

  **Hypertension**                                 1                    4                     

                                                                                              

  ***Flap Length (cm)***                           ***15***             ***11.9***            ***0.009***

                                                                                              

  **Thickness of flap (mm)**                                                                  

   Superior                                        3.0                  4.2                   0.201

   Inferior                                        3.0                  4.4                   0.100

   Lateral                                         4.0                  40                    1.000

   Medial                                          4.0                  4.0                   1.000

                                                                                              

  **Pre-operative Tissue Oxygenation (StO2)**                                                 

   Superior                                        59.0                 60.9                  0.910

   ***Inferior***                                  ***94.0***           ***49.1***            ***0.0017***

   Lateral                                         73.5                 58.2                  0.371

   Medial                                          68.5                 58.5                  0.540

                                                                                              

  **Post-operative Tissue Oxygenation (StO2)**                                                

   Superior                                        28                   54.4                  0.083

   Inferior                                        29                   59.0                  0.199

   Lateral                                         50                   62.2                  .0586

   Medial                                          27                   65.2                  0.058

                                                                                              

  **Changes in Tissue Oxygenation**\                                                          
  **StO2 percent change (absolute StO2 change)**                                              

   Superior                                        -53% (-31.5)         -5.9% (-6.5)          0.280

   ***Inferior***                                  ***-69% (-65.5)***   ***+20% (+9.8)***     ***0.003***

   Lateral                                         -32% (-23.5)         +7.17% (+4.1)         0.145

   ***Medial***                                    ***-61% (-42)***     ***+14.6% (+6.7)***   ***0.018***

   Clavicular                                      +6% (+2)             +14.6% (+6.8)         0.850
  ----------------------------------------------------------------------------------------------------------

Variables analyzed, statistically significant variables are bold and italicized

Patient demographics are displayed in Table [2](#T2){ref-type="table"}. Fifty percent of patients were African-American, 40% were Hispanic, 10% were White. The average age was 49, average body mass index (BMI) was 27.9. There were two patients with diabetes and five with hypertension. None of the patients had chronic obstructive pulmonary disease (COPD) or admitted to smoking. Only one patient had evidence of tumor skin involvement. The stage of the primary tumor ranged from DCIS to T4D. Three patients had DCIS, and five had invasive ductal cancer. Five patients had undergone neoadjuvant chemotherapy, and one had previously received radiation to the chest wall. Average operative time was 109 minutes (60-180 min), a factor which was not significantly different between the two groups. The one patient with necrosis did have an expander in place, four of the patients without necrosis also had expanders, all of these patients underwent skin-sparing mastectomy. There were no nipple-sparing mastectomies in this cohort. The remaining five patients did not undergo immediate reconstruction and underwent mastectomy with a standard elliptical incision. Operative time, BMI, tumor pathology, tumor size, patient age and operating surgeon were not significant factors in predicting necrosis.

###### 

Patient Demographics

  Factor                        \% (n)
  ----------------------------- ---------
  **Average Age**               49
                                
  **Race**                      
   White                        10% (1)
   African American             50% (5)
   Hispanic                     40% (4)
                                
  **Body Mass Index (BMI)**     
   Average                      27.9
                                
  **Smoking**                   0% (0)
                                
  **Co-morbidities**            
   Diabetes                     20% (2)
   Hypertension                 50% (5)
   COPD                         0% (0)
                                
  **Skin Involvement**          
   None                         80% (8)
   Skin retraction              10% (1)
                                
  **Clinical T Size**           
   Tis                          30% (3)
   T0                           10% (1)
   T1                           30% (3)
   T3                           10% (1)
   T4A                          10% (1)
   T4D                          10% (1)
                                
  **Histology**                 
   DCIS                         30% (3)
   Invasive Ductal              50% (5)
   Invasive Lobular             10% (1)
   Other                        10% (1)
                                
  **Neoadjuvant Chemo**         50% (5)
                                
  **Radiation to Chest Wall**   10%(10)

The patient with 108 cm^2^of necrosis (Figure [2](#F2){ref-type="fig"}) underwent skin-sparing mastectomy, sentinel node biopsy and immediate reconstruction with expander placement. The expander was not filled intra-operatively. This patient had uniquely significant drops in StO~2~measurements post-operatively (Figure [2](#F2){ref-type="fig"}). This patient had full thickness necrosis in several areas of the mastectomy skin flap. She did have a personal history of Hepatitis C, sarcoidosis, and hypertension. Intraoperative fluorescein dye injection was also used to assess mastectomy skin flap viability and did indicate a possible perfusion deficit at the 2 o\' clock position. Due to the overlying skin necrosis and consequent exposed expander, she required expander removal and skin graft two months after her mastectomy.

![**A patient with significant intraoperative decrease in StO~2~**. Decreases were: 53%, 69%, 61%, and 32% at superior, inferior, medial, and lateral, respectively.](1477-7819-7-91-2){#F2}

Discussion
==========

One commonly used tool to evaluate mastectomy flap viability intra-operatively is the intravenous sodium fluorescein test (Wood\'s lamp method). This involves intravenous injection of fluorescein followed by intra-operative evaluation with a Wood\'s lamp. Although it has been available since 1931, its application is prone to subjective errors, and is limited to over/under reading by as much as 30% \[[@B10]\]. It is also a test of vascularity - not viability, and subject to changes in vascularity such as vasospasm, intravascular clotting, or alterations in the distribution of the microcirculation. Alternatively the use of infrared spectroscopy takes into account metabolic changes of the dissected tissue, and potentially allows trends to be followed for flap evaluation post-operatively.

The arterial supply of the breast is generally defined as an anastomotic plexus of vessels originating from the axillary artery, the internal mammary artery, the intercostal arteries, and lateral thoracic artery. The contribution of each individual artery and the consequences of vascular interruption are poorly understood, but the course of the nerves and vessels may be related to the ligamentous apparatus \[[@B11]\]. One such horizontal ligamentous suspension originates from the pectoral fascia along the 5^th^rib \[[@B12]\]. Our finding that the decrease in perfusion from the inferior portion of the breast most accurately predicted post-operative epidermolysis may be supportive of this finding.

In addition, there currently does not exist any standardized method for measuring mastectomy skin flap thickness during an operation, further refinements in this technique-i.e. the use of calipers, may be helpful for future trials.

Traditionally, surgeons are careful to avoid transection of medial perforators. Consistent with this, our data demonstrate an increased likelihood of necrosis in the patient who had a significant decrease in medial StO~2~measurements. This may be particularly important in those patients who undergo disruption of the medial perforators secondary to internal mammary node dissection.

There are significant limitations to this study. Most notable is the small sample size. Contributions from underlying co-morbidities (coronary artery disease, diabetes) may be more readily apparent with a larger sample size. In addition, this study population was predominately a minority population; there is an under-representation of Caucasian patients. Although the ViOptix T.Ox Tissue Oximeter system has been validated in several racial groups, there may be variability in StO~2~measurements between races which can only be further elucidated with a large sample size. For further studies, assuming a 10% necrosis rate, a sample of 40 patients will provide more than 90% power to detect a two standard deviation difference of the mean StO~2~measures (significance level is held at 0.05, two sided). Clearly a group of patients undergoing skin-sparing mastectomy with immediate reconstruction would provide the most useful clinical information as these patients are more likely to have difficulties with wound healing and face the greatest consequences (implant extrusion, flap failure) from poor wound healing.

It is known that the perfusion to the subdermal plexus of the skin is controlled by the autonomic nervous system in response to variations in metabolic demands and environment. All patients in this study were stable intra-operatively. However, the actual oxygen saturation and blood pressure measurements at the time of StO~2~measurement were not evaluated, the influence of these factors will be examined in future studies. The patient with necrosis had drops in StO~2~measurement, which also may be an indicator of failure to compensate for injury, whereas the patients who did not have necrosis, for the most part, had increased StO~2~levels after dissection, potentially indicating an ability to increase perfusion appropriately to the area of injury.

Similarly, wound healing is a complicated process. Factors contributing to or complicating the wound healing process include body habitus, age, co-morbidities, prolonged operative time, collagen disorders, infection, history of radiation exposure, immune status, and steroid use \[[@B13]-[@B15]\].

Lastly, a review of the patient response to the ViOptix T.Ox Tissue Oximeter system indicates that the patient having necrosis also had a longer flap length. This would appear to be consistent with the concept that the blood supply of longer flaps is more tenuous, likely due to the greater area of vascular disruption required when a mastectomy is performed.

Conclusion
==========

Commonly used intraoperative methods to determine flap viability include detection of skin discoloration, wound edge bleeding and intra-operative assessment with fluorescein and a Wood\'s Lamp. The use of near-infrared reflection spectroscopy to monitor myocutaneous flaps has been previously validated in humans \[[@B9]\]. Our study indicates that ViOptix T.Ox Tissue Oximeter is a non-invasive method which may be utilized to identify impaired perfusion in mastectomy skin flaps. It could potentially add valuable information to clinical observation, and may be able to detect early vascular complications. Areas which demonstrate sub-optimal perfusion can therefore be excised intra-operatively to potentially decrease wound complications and improve cosmetic outcome, alternatively, reconstruction may also be postponed until a later date or potentially an autologous reconstruction may be considered. Further studies are planned with a larger sample size for validation, and to establish standards.
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